Regions with known anatomical interconnections that show consistent changes across
converging imaging experiments form the basis of this model. Regions are grouped
into four main compartments, reflecting general behavioral dimensions of MDD and
regional targets of various antidepressant treatments. Regions within a
compartment all have strong anatomical connections to one another. Black arrows
identify cross-compartment anatomical connections. Solid colored arrows identify
putative connections between compartments mediating a specific treatment: green
indicates CBT; blue indicates pharmacotherapy; red indicates SCC DBS. a-ins,
anterior insula; amg, amygdala; dm-Th, dorsomedial thalamus; dp-Hc,
dorsal-posterior hippocampus; mb-vta, midbrain-ventral tegmental area; mF10/9,
medial frontal cortex BA10 and BA9; mOF11, medial orbital frontal cortex BA11;
Par40, parietal cortex BA40; PF46/9, prefrontal cortex BA46 and BA9; PM6, premotor
cortex BA6; va-HC, ventral-anterior hippocampus; vst-cd, ventral
striatum-caudate.